A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics
Article in Blood (March 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma
Article in Nature Communications (March 2024)
Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation
Article in Nature Cancer (August 2023)